MBII: Grandevo WDG approved for patent issuance

By Ian Gilson, PhD, CFA

NASDAQ:MBII

READ THE FULL MBII RESEARCH REPORT

On June 25, 2019, Marrone Bio Innovations (NASDAQ:MBII) received notice that the major claims covering composition and method of manufacture of Grandevo WDG have been allowed.

This means that the patent covering these claims will be issued will be issued in the near future. The family of Grandevo products are an important source of revenue.

This bioinsecticide/miticide kills a large number of sucking pests on a wide variety of crops. The product can be sprayed up to the time of harvesting and there are no toxicity or residue problems.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. 

DISCLOSURE: Zacks SCR has received compensation from the issuer directly or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $30,000 annually for these services. Full Disclaimer HERE.

COMMENTS

WORDPRESS: 0
DISQUS: 0